USPSTF 2022: screening for atrial fibrillation

Context Adults 50 or older without an AF diagnosis or symptoms (USPSTF 2022 AF screening statement)

Recipient

Adult

Population

Adults aged 50 or older with no diagnosis or symptoms of atrial fibrillation and no earlier transient ischemic attack or stroke, as the abstract defines the population. The abstract describes the recommendation as concerning asymptomatic adults.

Care setting

Not stated in the abstract.

Geography

United States (a USPSTF recommendation)

Life stage

Adults aged 50 or older

Follow-up

Not applicable (guideline context)

• Recommendation Guidance Certainty not assessed

  For asymptomatic adults aged 50 or older, the USPSTF finds the evidence now available too limited to judge whether screening for atrial fibrillation does more good than harm (an I statement). The abstract says evidence is lacking, so the balance cannot be determined.

  Applies to Adult

  • Adults aged 50 or older with no diagnosis or symptoms of atrial fibrillation and no earlier transient ischemic attack or stroke, as the abstract defines the population. The abstract describes the recommendation as concerning asymptomatic adults.
  • Not stated in the abstract.
  • United States (a USPSTF recommendation)
  • Adults aged 50 or older

  Follow-up Not applicable (guideline context)

  Certainty method

  Not assessed

  Limitations

  An I statement means the evidence is too thin to support a recommendation either way. It is not advice against screening, and it does not say that screening finds nothing or that anticoagulation does not help. The statement updates a 2018 recommendation. Only the PubMed abstract and the date line of the USPSTF page were read. No recommendation record is written, because this atlas has no record for atrial fibrillation screening itself.

  Last checked

  2026-10-15

  Next evidence check due

  Not scheduled

  Sources and citations (5)

  1. Supports Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement

     Guideline · JAMA · Edition Recommendation statement published in JAMA 2022;327(4):360-367. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement. · Published 2022-01-25 · DOI: 10.1001/jama.2021.23732 · PMID: 35076659

     Locator

     Abstract, RECOMMENDATION, sentence 1

     How it applies

     Evidence insufficient to assess benefits and harms of screening.

     Retrieved

     2026-10-15T13:48:56Z

     Source effective date

     Not reported

     Source state

     Current

     Snapshot hash

     b6eca7cc7d6b7dbcbcad87b38e8110eda733e7a3b44642b6f83a720a3fab9b51

     Reuse basis

     PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The USPSTF copyright notice (see source core:uspstf-about) lets the public reproduce USPSTF work only without changes, except as fair use, and asks that the USPSTF page be cited. That is not clear permission to repost wording, so public text is cite_only: public pages state the recommendation in the atlas's own words, with a citation and a link. The notice also says the work may not be sold for profit or folded into a profit-making venture without written permission from AHRQ (see source cardio:uspstf-copyright-notice, fetched 2026-10-15). Whether the atlas counts as such a venture is not settled here, so every USPSTF fact is kept in the atlas's own words. Quote rows from the abstract are short evidence fragments for the reviewer, and the USPSTF page is quoted only for its date line.

  2. Supports Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement

     Guideline · JAMA · Edition Recommendation statement published in JAMA 2022;327(4):360-367. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement. · Published 2022-01-25 · DOI: 10.1001/jama.2021.23732 · PMID: 35076659

     Locator

     Abstract, RECOMMENDATION, sentence 2

     How it applies

     The I statement label.

     Retrieved

     2026-10-15T13:48:56Z

     Source effective date

     Not reported

     Source state

     Current

     Snapshot hash

     b6eca7cc7d6b7dbcbcad87b38e8110eda733e7a3b44642b6f83a720a3fab9b51

     Reuse basis

     PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The USPSTF copyright notice (see source core:uspstf-about) lets the public reproduce USPSTF work only without changes, except as fair use, and asks that the USPSTF page be cited. That is not clear permission to repost wording, so public text is cite_only: public pages state the recommendation in the atlas's own words, with a citation and a link. The notice also says the work may not be sold for profit or folded into a profit-making venture without written permission from AHRQ (see source cardio:uspstf-copyright-notice, fetched 2026-10-15). Whether the atlas counts as such a venture is not settled here, so every USPSTF fact is kept in the atlas's own words. Quote rows from the abstract are short evidence fragments for the reviewer, and the USPSTF page is quoted only for its date line.

  3. Supports Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement

     Guideline · JAMA · Edition Recommendation statement published in JAMA 2022;327(4):360-367. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement. · Published 2022-01-25 · DOI: 10.1001/jama.2021.23732 · PMID: 35076659

     Locator

     Abstract, EVIDENCE ASSESSMENT, sentence 1

     How it applies

     Evidence is lacking; the balance cannot be determined.

     Retrieved

     2026-10-15T13:48:56Z

     Source effective date

     Not reported

     Source state

     Current

     Snapshot hash

     b6eca7cc7d6b7dbcbcad87b38e8110eda733e7a3b44642b6f83a720a3fab9b51

     Reuse basis

     PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The USPSTF copyright notice (see source core:uspstf-about) lets the public reproduce USPSTF work only without changes, except as fair use, and asks that the USPSTF page be cited. That is not clear permission to repost wording, so public text is cite_only: public pages state the recommendation in the atlas's own words, with a citation and a link. The notice also says the work may not be sold for profit or folded into a profit-making venture without written permission from AHRQ (see source cardio:uspstf-copyright-notice, fetched 2026-10-15). Whether the atlas counts as such a venture is not settled here, so every USPSTF fact is kept in the atlas's own words. Quote rows from the abstract are short evidence fragments for the reviewer, and the USPSTF page is quoted only for its date line.

  4. Background Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement

     Guideline · JAMA · Edition Recommendation statement published in JAMA 2022;327(4):360-367. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement. · Published 2022-01-25 · DOI: 10.1001/jama.2021.23732 · PMID: 35076659

     Locator

     Abstract, POPULATION, sentence 1

     How it applies

     Adults 50 or older without AF diagnosis or symptoms and without a past TIA or stroke.

     Retrieved

     2026-10-15T13:48:56Z

     Source effective date

     Not reported

     Source state

     Current

     Snapshot hash

     b6eca7cc7d6b7dbcbcad87b38e8110eda733e7a3b44642b6f83a720a3fab9b51

     Reuse basis

     PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The USPSTF copyright notice (see source core:uspstf-about) lets the public reproduce USPSTF work only without changes, except as fair use, and asks that the USPSTF page be cited. That is not clear permission to repost wording, so public text is cite_only: public pages state the recommendation in the atlas's own words, with a citation and a link. The notice also says the work may not be sold for profit or folded into a profit-making venture without written permission from AHRQ (see source cardio:uspstf-copyright-notice, fetched 2026-10-15). Whether the atlas counts as such a venture is not settled here, so every USPSTF fact is kept in the atlas's own words. Quote rows from the abstract are short evidence fragments for the reviewer, and the USPSTF page is quoted only for its date line.

  5. Background Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement

     Guideline · JAMA · Edition Recommendation statement published in JAMA 2022;327(4):360-367. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement. · Published 2022-01-25 · DOI: 10.1001/jama.2021.23732 · PMID: 35076659

     Locator

     Page header, date line of the final recommendation statement

     How it applies

     Date of the final statement.

     Retrieved

     2026-10-15T13:55:02Z

     Source effective date

     Not reported

     Source state

     Current

     Snapshot hash

     6ffd2cc2c0ec40a3ad29ec16eb7fc53d39466663bb1d3e28d75559568a4a7ba2

     Reuse basis

     PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The USPSTF copyright notice (see source core:uspstf-about) lets the public reproduce USPSTF work only without changes, except as fair use, and asks that the USPSTF page be cited. That is not clear permission to repost wording, so public text is cite_only: public pages state the recommendation in the atlas's own words, with a citation and a link. The notice also says the work may not be sold for profit or folded into a profit-making venture without written permission from AHRQ (see source cardio:uspstf-copyright-notice, fetched 2026-10-15). Whether the atlas counts as such a venture is not settled here, so every USPSTF fact is kept in the atlas's own words. Quote rows from the abstract are short evidence fragments for the reviewer, and the USPSTF page is quoted only for its date line.